Clinical Trial Update: Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Isatuximab plus pomalidomide and dexamethasone for AL amyloidosis patients not achieving VGPR or better after prior therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Isatuximab (isatuximab)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Intergroupe Francophone du Myelome | Conditions: AL Amyloidosis | Phase 2 | Status: UNKNOWN